Dr. Yerem Yeghiazarians, MD

Dr. Yeghiazarians practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Yeghiazarians' NPI, 1265477988, was assigned on June 17, 2006. Dr. Yeghiazarians graduated from The Johns Hopkins University School of Medicine in 1995. Dr. Yeghiazarians holds California license A83865.

Dr. Yeghiazarians' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Yeghiazarians' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Yeghiazarians is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Yeghiazarians to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yeghiazarians practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Yeghiazarians' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Yeghiazarians is board certified in interventional cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Yeghiazarians' licenses on file in 2 states: California and Massachusetts.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Yeghiazarians treats.

CMS data shows 183 Medicare services from Dr. Yeghiazarians across 8 procedure codes in 2024, for 150 Medicare patients. Medicare paid $33,237 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Yeghiazarians in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yeghiazarians' median patient age at 70, with 34% women.

In 2024, Dr. Yeghiazarians wrote 507 Medicare Part D claims for 77 patients. 85% of them were for generic drugs. CMS names the drug for 394 of them, across 12 drugs with 11 or more claims each, at $68,772 in total drug cost. In 2023, CMS named 520 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Yeghiazarians for performance year 2024, reported as part of a group. Dr. Yeghiazarians accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yeghiazarians as offering telehealth. CMS counts 16 procedures of coronary angioplasty and stenting by Dr. Yeghiazarians, more than 42% of the clinicians it reports for that procedure.

Dmand AI links 57 papers to Dr. Yeghiazarians, published from 2009 to 2022. 2011 was the busiest year, with 10. The most frequent topics are Myocytes, Cardiac, Cells, Cultured and Myocardial Infarction. Dr. Yeghiazarians has published most often in Am J Cardiovasc Dis. Dr. Yeghiazarians' most frequent co-authors are Andrew John Boyle, MD, Thomas A. Ports, MD and William J. Grossman, MD.

CMS Open Payments shows 119 general payments to Dr. Yeghiazarians from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Bristol-Myers Squibb Company paid the most, $4,472.

Dr. Yeghiazarians graduated from The Johns Hopkins University School of Medicine in 1995. Dr. Yeghiazarians is a member of ACC.

Dr. Yeghiazarians is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.